Výsledky vyhledávání

Akademický článek

Accuracy of the CellaVision DM96 platform for reticulocyte counting

Autor: Etienne R. Mahe, Diane Higa, Christopher Naugler, Adnan Mansoor, Meer-Taher Shabani-Rad

Publikováno v: Journal of Pathology Informatics, Vol 5, Iss 1, Pp 17-17 (2014)

Context: Many hematology laboratories have adopted semi-automated digital platforms for routine use and the evidence supporting their use is increasing. Aims: The CellaVision platforms are among the most thoroughly studied digital hematology platform

Externí odkaz: https://doaj.org/article/cee0a89680be484aa9099f2514240c67

Zobrazit plný text záznamu

Report

Meet-reducible submaximal clones determined by nontrivial equivalence relations

Autor: Diekouam, Luc E. F., Temgoua, Etienne R. A., Tonga, Marcel

The structure of the lattice of clones on a finite set has been proven to be very complex. To better understand the top of this lattice, it is important to provide a characterization of submaximal clones in the lattice of clones. It is known that the

Externí odkaz: http://arxiv.org/abs/1611.06574

Zobrazit plný text záznamu

Report

Meet-reducible submaximal clones determined by two central relations

Autor: Yannick, Jeufack L. T., Diekouam, Luc E. F., Temgoua, Etienne R. A.

Let rho and sigma be two central relations on a finite set A. It is known that the clones Pol(rho) and Pol(sigma) which consists of all operations on A that preserve rho respectively sigma are among the maximal clones on A. In this paper, we find all

Externí odkaz: http://arxiv.org/abs/1610.07834

Zobrazit plný text záznamu

Akademický článek

Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials

Autor: Arnaud Bayle, Laila Belcaid, Sophie Cousin, Kilian Trin, Melissa Alame, Etienne Rouleau, Isabelle Soubeyran, Ludovic Lacroix, Laura Blouin, Damien Vasseur, Amandine Crombe, Simone Mathoulin-Pelissier, Jean-Charles Soria, Carine Bellera, Antoine Italiano

Publikováno v: npj Precision Oncology, Vol 8, Iss 1, Pp 1-5 (2024)

Abstract Selecting patients for phase I cancer trials is crucial to ensure a sufficient life expectancy. Frail patients, better suited for palliative care, should not be exposed to new drugs with minimal benefit. Enrolling patients at high risk of ea

Externí odkaz: https://doaj.org/article/d05aae3b04e145588413b39998d26d59

Zobrazit plný text záznamu